Mucinous tumor

WikiDoc Resources for Mucinous tumor
Articles
Most recent articles on Mucinous tumor Most cited articles on Mucinous tumor Review articles on Mucinous tumor Articles on Mucinous tumor in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mucinous tumor Images of Mucinous tumor Photos of Mucinous tumor Podcasts & MP3s on Mucinous tumor Videos on Mucinous tumor
Evidence Based Medicine
Cochrane Collaboration on Mucinous tumor Bandolier on Mucinous tumor TRIP on Mucinous tumor
Clinical Trials
Ongoing Trials on Mucinous tumor at Clinical Trials.gov Trial results on Mucinous tumor Clinical Trials on Mucinous tumor at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mucinous tumor NICE Guidance on Mucinous tumor NHS PRODIGY Guidance FDA on Mucinous tumor CDC on Mucinous tumor
Books
Books on Mucinous tumor
News
Mucinous tumor in the news Be alerted to news on Mucinous tumor News trends on Mucinous tumor
Commentary
Blogs on Mucinous tumor
Definitions
Definitions of Mucinous tumor
Patient Resources / Community
Patient resources on Mucinous tumor Discussion groups on Mucinous tumor Patient Handouts on Mucinous tumor Directions to Hospitals Treating Mucinous tumor Risk calculators and risk factors for Mucinous tumor
Healthcare Provider Resources
Symptoms of Mucinous tumor Causes & Risk Factors for Mucinous tumor Diagnostic studies for Mucinous tumor Treatment of Mucinous tumor
Continuing Medical Education (CME)
CME Programs on Mucinous tumor
International
Mucinous tumor en Espanol Mucinous tumor en Francais
Business
Mucinous tumor in the Marketplace Patents on Mucinous tumor
Experimental / Informatics
List of terms related to Mucinous tumor

Overview

Mucinous tumors are part of the surface epithelial-stromal tumor group of ovarian neoplasms, and account for 12-15% of all ovarian tumors. Approximately 75% are benign, 10% are borderline and 15% are malignant. Rarely, the tumor is seen bilaterally, approximately 5% of primary mucinous tumors are bilateral.

Benign mucinous tumors are typically multilocular (have several lobes), and the cysts have a smooth lining of epithelium that resembles endocervical epithelial cells with small numbers of gastrointestinal-type epithelial cells. Borderline and malignant mucinous tumors often have papillae and solid areas. There may also be hemorrhage and necrosis. It is well-documented that malignancy may be only focally present in mucinous neoplasms of the ovary, so thorough sampling is imperative.

The major distinguishing features of mucinous tumors are that the tumors are filled with a mucus-like material, which gives them their name; this mucus is produced by mucus-secreting goblet cells very similar to the cells lining normal intestine.

These tumors may become very large, some have been weighed as large as 25 kilograms.

Cystadenocarcinomas (malignant tumors) contain a more solid growth pattern with the hallmarks of malignancy: cellular atypia and stratification, loss of the normal architecture of the tissu, and necrosis. The appearance can look similar to colonic cancer. Clear stromal invasion is used to differentiate borderline tumors from malignant tumors.

Pseudomyxoma peritonei may present as a result of an ovarian mucinous tumor, however this is a rare cause of this condition, which is a rare condition. A more common cause of pseudomyxoma peritonei is a mucin-producing tumor of the appendix.

Since mucinous tumors arising from the ovary usually only involve one ovary, the presence of involvement in both ovaries with a mucinous tumor suggests that the tumor may have arisen in another location, and further study is warranted.

Prognosis 10-year survival rates for mucinous tumors is excellent in the absence of invasion. In the case of boderline tumors confined to the ovary and malignant tumors without invasion, the survival rates are 90% or greater. In invasive mucinous cystadenocarcinomas, the survival is approximately 66%. Template:WH Template:WS